Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Thyroid Neoplasms × Sorafenib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 OTHER 3 NIH 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 3 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Liver Neoplasms 1 Carcinoma 1

Interventions

Iodine-131 2 Thyroidectomy 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiotherapy, Intensity-Modulated 1 Iodine-123 1 Anterior Temporal Lobectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02084732 2019-11-13

Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study

Instituto Nacional de Cancerologia, Columbia

Phase 2 Completed

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡